Trial intelligence / Profile preview

L-Carnitine Injection in Heart Failure

NCT01580553Phase 3Completed

Sponsor
Lee's Pharmaceutical Holdings Limited
Start
Jan 2011
Primary completion
Mar 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of levocarnitine in heart failure (HF), sponsored by Lee's Pharmaceutical Holdings Limited. Started Jan 2011; status: completed.

02

Drugs

levocarnitine
03

Conditions

heart failure (HF)

Beyond the preview

Go deeper on NCT01580553.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01580553.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call